nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CHRM2—type 1 diabetes mellitus	0.634	1	CbGaD
Ziprasidone—HTR7—umbilical artery—type 1 diabetes mellitus	0.015	0.192	CbGeAlD
Ziprasidone—HTR2A—arteriole—type 1 diabetes mellitus	0.00536	0.0688	CbGeAlD
Ziprasidone—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.00368	0.0472	CbGeAlD
Ziprasidone—DRD1—nerve—type 1 diabetes mellitus	0.00331	0.0425	CbGeAlD
Ziprasidone—HTR3A—nerve—type 1 diabetes mellitus	0.0032	0.0411	CbGeAlD
Ziprasidone—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00266	0.0341	CbGeAlD
Ziprasidone—Psoriasis—Ramipril—type 1 diabetes mellitus	0.0024	0.0276	CcSEcCtD
Ziprasidone—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.0023	0.0295	CbGeAlD
Ziprasidone—HTR7—nerve—type 1 diabetes mellitus	0.00207	0.0266	CbGeAlD
Ziprasidone—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.00202	0.0232	CcSEcCtD
Ziprasidone—DRD2—nerve—type 1 diabetes mellitus	0.00196	0.0251	CbGeAlD
Ziprasidone—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00195	0.025	CbGeAlD
Ziprasidone—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00174	0.02	CcSEcCtD
Ziprasidone—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.00172	0.0197	CcSEcCtD
Ziprasidone—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00166	0.0213	CbGeAlD
Ziprasidone—Cough increased—Ramipril—type 1 diabetes mellitus	0.00165	0.019	CcSEcCtD
Ziprasidone—Drug interaction—Ramipril—type 1 diabetes mellitus	0.00163	0.0187	CcSEcCtD
Ziprasidone—H1F0—islet of Langerhans—type 1 diabetes mellitus	0.00163	0.0209	CbGeAlD
Ziprasidone—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00161	0.0185	CcSEcCtD
Ziprasidone—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00159	0.0182	CcSEcCtD
Ziprasidone—HTR3A—islet of Langerhans—type 1 diabetes mellitus	0.00155	0.0199	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.0015	0.0193	CbGeAlD
Ziprasidone—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00147	0.0169	CcSEcCtD
Ziprasidone—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00142	0.0164	CcSEcCtD
Ziprasidone—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00142	0.0163	CcSEcCtD
Ziprasidone—H1F0—retina—type 1 diabetes mellitus	0.00139	0.0178	CbGeAlD
Ziprasidone—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00137	0.0158	CcSEcCtD
Ziprasidone—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00136	0.0157	CcSEcCtD
Ziprasidone—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00135	0.0155	CcSEcCtD
Ziprasidone—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00135	0.0155	CcSEcCtD
Ziprasidone—Aripiprazole—CHRM2—type 1 diabetes mellitus	0.00133	0.418	CrCbGaD
Ziprasidone—H1F0—nephron tubule—type 1 diabetes mellitus	0.00131	0.0168	CbGeAlD
Ziprasidone—HTR2A—nerve—type 1 diabetes mellitus	0.00129	0.0166	CbGeAlD
Ziprasidone—DRD5—lymphoid tissue—type 1 diabetes mellitus	0.00128	0.0164	CbGeAlD
Ziprasidone—Polyuria—Ramipril—type 1 diabetes mellitus	0.00125	0.0143	CcSEcCtD
Ziprasidone—ADRA1B—kidney—type 1 diabetes mellitus	0.00122	0.0156	CbGeAlD
Ziprasidone—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00119	0.0136	CcSEcCtD
Ziprasidone—H1F0—cardiovascular system—type 1 diabetes mellitus	0.00118	0.0151	CbGeAlD
Ziprasidone—Amnesia—Ramipril—type 1 diabetes mellitus	0.00117	0.0134	CcSEcCtD
Ziprasidone—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00116	0.0133	CcSEcCtD
Ziprasidone—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00116	0.0133	CcSEcCtD
Ziprasidone—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00115	0.0132	CcSEcCtD
Ziprasidone—H1F0—kidney—type 1 diabetes mellitus	0.00115	0.0148	CbGeAlD
Ziprasidone—H1F0—pancreas—type 1 diabetes mellitus	0.00114	0.0147	CbGeAlD
Ziprasidone—Aripiprazole—ADRB1—type 1 diabetes mellitus	0.00113	0.357	CrCbGaD
Ziprasidone—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00112	0.0129	CcSEcCtD
Ziprasidone—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00112	0.0129	CcSEcCtD
Ziprasidone—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.0011	0.0126	CcSEcCtD
Ziprasidone—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00103	0.0118	CcSEcCtD
Ziprasidone—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00101	0.0116	CcSEcCtD
Ziprasidone—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.001	0.0115	CcSEcCtD
Ziprasidone—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00099	0.0114	CcSEcCtD
Ziprasidone—H1F0—lymphoid tissue—type 1 diabetes mellitus	0.000988	0.0127	CbGeAlD
Ziprasidone—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.000986	0.0113	CcSEcCtD
Ziprasidone—Gastritis—Ramipril—type 1 diabetes mellitus	0.000969	0.0111	CcSEcCtD
Ziprasidone—Influenza—Ramipril—type 1 diabetes mellitus	0.000947	0.0109	CcSEcCtD
Ziprasidone—Dysphagia—Ramipril—type 1 diabetes mellitus	0.000947	0.0109	CcSEcCtD
Ziprasidone—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.000941	0.0121	CbGeAlD
Ziprasidone—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.000937	0.0108	CcSEcCtD
Ziprasidone—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000936	0.012	CbGeAlD
Ziprasidone—KCNH2—islet of Langerhans—type 1 diabetes mellitus	0.000935	0.012	CbGeAlD
Ziprasidone—Sweating increased—Ramipril—type 1 diabetes mellitus	0.000922	0.0106	CcSEcCtD
Ziprasidone—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.000922	0.0106	CcSEcCtD
Ziprasidone—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.000911	0.0117	CbGeAlD
Ziprasidone—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.000908	0.0104	CcSEcCtD
Ziprasidone—HTR1D—kidney—type 1 diabetes mellitus	0.000891	0.0114	CbGeAlD
Ziprasidone—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00088	0.0101	CcSEcCtD
Ziprasidone—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000872	0.01	CcSEcCtD
Ziprasidone—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000864	0.00994	CcSEcCtD
Ziprasidone—Weight increased—Ramipril—type 1 diabetes mellitus	0.000862	0.00991	CcSEcCtD
Ziprasidone—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.000852	0.0109	CbGeAlD
Ziprasidone—Renal failure—Ramipril—type 1 diabetes mellitus	0.00083	0.00954	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000827	0.00951	CcSEcCtD
Ziprasidone—Jaundice—Ramipril—type 1 diabetes mellitus	0.000823	0.00946	CcSEcCtD
Ziprasidone—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.000821	0.00943	CcSEcCtD
Ziprasidone—DRD2—retina—type 1 diabetes mellitus	0.000811	0.0104	CbGeAlD
Ziprasidone—Sweating—Ramipril—type 1 diabetes mellitus	0.000809	0.00931	CcSEcCtD
Ziprasidone—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000796	0.00915	CcSEcCtD
Ziprasidone—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.000772	0.0099	CbGeAlD
Ziprasidone—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000759	0.00974	CbGeAlD
Ziprasidone—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000758	0.00871	CcSEcCtD
Ziprasidone—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000746	0.00858	CcSEcCtD
Ziprasidone—CHRM3—kidney—type 1 diabetes mellitus	0.000746	0.00957	CbGeAlD
Ziprasidone—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000745	0.00856	CcSEcCtD
Ziprasidone—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000742	0.00953	CbGeAlD
Ziprasidone—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000736	0.00944	CbGeAlD
Ziprasidone—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00073	0.0084	CcSEcCtD
Ziprasidone—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000726	0.00931	CbGeAlD
Ziprasidone—Clozapine—CHRM2—type 1 diabetes mellitus	0.000714	0.225	CrCbGaD
Ziprasidone—HTR7—kidney—type 1 diabetes mellitus	0.00071	0.00911	CbGeAlD
Ziprasidone—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000707	0.00812	CcSEcCtD
Ziprasidone—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.0007	0.00898	CbGeAlD
Ziprasidone—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000684	0.00787	CcSEcCtD
Ziprasidone—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000683	0.00785	CcSEcCtD
Ziprasidone—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000677	0.00778	CcSEcCtD
Ziprasidone—KCNH2—cardiovascular system—type 1 diabetes mellitus	0.000676	0.00867	CbGeAlD
Ziprasidone—Alopecia—Ramipril—type 1 diabetes mellitus	0.00067	0.0077	CcSEcCtD
Ziprasidone—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000664	0.00763	CcSEcCtD
Ziprasidone—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00066	0.00759	CcSEcCtD
Ziprasidone—Erythema—Ramipril—type 1 diabetes mellitus	0.00066	0.00759	CcSEcCtD
Ziprasidone—ADRA2C—kidney—type 1 diabetes mellitus	0.000653	0.00837	CbGeAlD
Ziprasidone—ADRA2C—pancreas—type 1 diabetes mellitus	0.000648	0.00832	CbGeAlD
Ziprasidone—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000634	0.00729	CcSEcCtD
Ziprasidone—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.000621	0.00797	CbGeAlD
Ziprasidone—Tremor—Ramipril—type 1 diabetes mellitus	0.000618	0.00711	CcSEcCtD
Ziprasidone—Agitation—Ramipril—type 1 diabetes mellitus	0.000606	0.00697	CcSEcCtD
Ziprasidone—Angioedema—Ramipril—type 1 diabetes mellitus	0.000603	0.00693	CcSEcCtD
Ziprasidone—Vertigo—Ramipril—type 1 diabetes mellitus	0.000593	0.00681	CcSEcCtD
Ziprasidone—Syncope—Ramipril—type 1 diabetes mellitus	0.000592	0.0068	CcSEcCtD
Ziprasidone—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00059	0.00679	CcSEcCtD
Ziprasidone—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000588	0.00755	CbGeAlD
Ziprasidone—Palpitations—Ramipril—type 1 diabetes mellitus	0.000583	0.0067	CcSEcCtD
Ziprasidone—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00058	0.00667	CcSEcCtD
Ziprasidone—Cough—Ramipril—type 1 diabetes mellitus	0.000576	0.00662	CcSEcCtD
Ziprasidone—Chest pain—Ramipril—type 1 diabetes mellitus	0.000562	0.00646	CcSEcCtD
Ziprasidone—Myalgia—Ramipril—type 1 diabetes mellitus	0.000562	0.00646	CcSEcCtD
Ziprasidone—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000562	0.00646	CcSEcCtD
Ziprasidone—Anxiety—Ramipril—type 1 diabetes mellitus	0.00056	0.00644	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000558	0.00641	CcSEcCtD
Ziprasidone—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000549	0.00632	CcSEcCtD
Ziprasidone—CYP3A5—kidney—type 1 diabetes mellitus	0.000546	0.00701	CbGeAlD
Ziprasidone—Confusional state—Ramipril—type 1 diabetes mellitus	0.000543	0.00624	CcSEcCtD
Ziprasidone—CYP3A5—pancreas—type 1 diabetes mellitus	0.000543	0.00696	CbGeAlD
Ziprasidone—HTR2A—retina—type 1 diabetes mellitus	0.000535	0.00686	CbGeAlD
Ziprasidone—Shock—Ramipril—type 1 diabetes mellitus	0.00053	0.00609	CcSEcCtD
Ziprasidone—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000528	0.00607	CcSEcCtD
Ziprasidone—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000527	0.00606	CcSEcCtD
Ziprasidone—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000525	0.00604	CcSEcCtD
Ziprasidone—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000523	0.00601	CcSEcCtD
Ziprasidone—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00052	0.00598	CcSEcCtD
Ziprasidone—ADRA2A—pancreas—type 1 diabetes mellitus	0.000517	0.00664	CbGeAlD
Ziprasidone—Anorexia—Ramipril—type 1 diabetes mellitus	0.000513	0.0059	CcSEcCtD
Ziprasidone—Hypotension—Ramipril—type 1 diabetes mellitus	0.000503	0.00578	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00049	0.00564	CcSEcCtD
Ziprasidone—Insomnia—Ramipril—type 1 diabetes mellitus	0.000487	0.0056	CcSEcCtD
Ziprasidone—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000483	0.00556	CcSEcCtD
Ziprasidone—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00048	0.00552	CcSEcCtD
Ziprasidone—Somnolence—Ramipril—type 1 diabetes mellitus	0.000479	0.0055	CcSEcCtD
Ziprasidone—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000474	0.00545	CcSEcCtD
Ziprasidone—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000468	0.00538	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000465	0.00534	CcSEcCtD
Ziprasidone—Fatigue—Ramipril—type 1 diabetes mellitus	0.000464	0.00534	CcSEcCtD
Ziprasidone—Constipation—Ramipril—type 1 diabetes mellitus	0.00046	0.00529	CcSEcCtD
Ziprasidone—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000452	0.00581	CbGeAlD
Ziprasidone—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000444	0.0051	CcSEcCtD
Ziprasidone—HTR2A—kidney—type 1 diabetes mellitus	0.000443	0.00568	CbGeAlD
Ziprasidone—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00044	0.00506	CcSEcCtD
Ziprasidone—Urticaria—Ramipril—type 1 diabetes mellitus	0.000428	0.00492	CcSEcCtD
Ziprasidone—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000426	0.00489	CcSEcCtD
Ziprasidone—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000426	0.00489	CcSEcCtD
Ziprasidone—CYP3A4—kidney—type 1 diabetes mellitus	0.00041	0.00526	CbGeAlD
Ziprasidone—CYP2D6—kidney—type 1 diabetes mellitus	0.000403	0.00518	CbGeAlD
Ziprasidone—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000397	0.00456	CcSEcCtD
Ziprasidone—Asthenia—Ramipril—type 1 diabetes mellitus	0.000386	0.00444	CcSEcCtD
Ziprasidone—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000368	0.00424	CcSEcCtD
Ziprasidone—Dizziness—Ramipril—type 1 diabetes mellitus	0.000356	0.00409	CcSEcCtD
Ziprasidone—Vomiting—Ramipril—type 1 diabetes mellitus	0.000342	0.00394	CcSEcCtD
Ziprasidone—Rash—Ramipril—type 1 diabetes mellitus	0.000339	0.0039	CcSEcCtD
Ziprasidone—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000339	0.0039	CcSEcCtD
Ziprasidone—Headache—Ramipril—type 1 diabetes mellitus	0.000337	0.00388	CcSEcCtD
Ziprasidone—Nausea—Ramipril—type 1 diabetes mellitus	0.00032	0.00368	CcSEcCtD
Ziprasidone—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	8.25e-06	4.18e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.23e-06	4.17e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	8.19e-06	4.15e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	8.13e-06	4.11e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.08e-06	4.09e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	8.06e-06	4.08e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8e-06	4.05e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.97e-06	4.04e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—INS—type 1 diabetes mellitus	7.97e-06	4.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	7.96e-06	4.03e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.93e-06	4.02e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	7.89e-06	4e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.86e-06	3.98e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	7.84e-06	3.97e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.83e-06	3.96e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.82e-06	3.96e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.81e-06	3.96e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	7.81e-06	3.95e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	7.8e-06	3.95e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.79e-06	3.95e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	7.78e-06	3.94e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.77e-06	3.93e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.76e-06	3.93e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.76e-06	3.93e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.75e-06	3.93e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	7.75e-06	3.92e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.75e-06	3.92e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.74e-06	3.92e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	7.74e-06	3.92e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.71e-06	3.91e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.69e-06	3.89e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.6e-06	3.85e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	7.59e-06	3.84e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	7.57e-06	3.83e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.55e-06	3.82e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	7.53e-06	3.81e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.52e-06	3.81e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.49e-06	3.79e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.48e-06	3.79e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.48e-06	3.79e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	7.47e-06	3.78e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.45e-06	3.77e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.43e-06	3.76e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	7.41e-06	3.75e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.38e-06	3.74e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	7.37e-06	3.73e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.33e-06	3.71e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	7.31e-06	3.7e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	7.3e-06	3.7e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.28e-06	3.69e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.24e-06	3.67e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	7.23e-06	3.66e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.2e-06	3.64e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	7.18e-06	3.64e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	7.18e-06	3.63e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.16e-06	3.63e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.13e-06	3.61e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	7.13e-06	3.61e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	7.11e-06	3.6e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.1e-06	3.59e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	7.08e-06	3.59e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.07e-06	3.58e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.07e-06	3.58e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.06e-06	3.58e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	7.06e-06	3.57e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	7.05e-06	3.57e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.02e-06	3.55e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	6.99e-06	3.54e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.98e-06	3.54e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.96e-06	3.53e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	6.96e-06	3.52e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.95e-06	3.52e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.91e-06	3.5e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	6.83e-06	3.46e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.82e-06	3.45e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.78e-06	3.44e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.73e-06	3.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.72e-06	3.4e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.72e-06	3.4e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—type 1 diabetes mellitus	6.72e-06	3.4e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	6.72e-06	3.4e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	6.7e-06	3.39e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	6.7e-06	3.39e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	6.7e-06	3.39e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.69e-06	3.39e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	6.68e-06	3.38e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	6.66e-06	3.37e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.64e-06	3.36e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	6.63e-06	3.36e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.62e-06	3.35e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.6e-06	3.34e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.6e-06	3.34e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.6e-06	3.34e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	6.6e-06	3.34e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	6.58e-06	3.33e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.57e-06	3.33e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.57e-06	3.33e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.57e-06	3.32e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.52e-06	3.3e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.5e-06	3.29e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.49e-06	3.29e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.48e-06	3.28e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.47e-06	3.28e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.47e-06	3.27e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.46e-06	3.27e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.45e-06	3.27e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.44e-06	3.26e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.43e-06	3.26e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.41e-06	3.25e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	6.41e-06	3.25e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.39e-06	3.23e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.38e-06	3.23e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.36e-06	3.22e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.35e-06	3.21e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.33e-06	3.21e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.28e-06	3.18e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.2e-06	3.14e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	6.14e-06	3.11e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	6.11e-06	3.09e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.1e-06	3.09e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	6.08e-06	3.08e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6e-06	3.04e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	6e-06	3.04e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.99e-06	3.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.99e-06	3.03e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.99e-06	3.03e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.97e-06	3.02e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.97e-06	3.02e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.97e-06	3.02e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.96e-06	3.02e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.95e-06	3.01e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—type 1 diabetes mellitus	5.95e-06	3.01e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.94e-06	3.01e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.93e-06	3e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.91e-06	2.99e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.89e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.89e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.88e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.88e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.88e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	5.87e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.86e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.84e-06	2.96e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.8e-06	2.94e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.79e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.79e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.78e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.77e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.76e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.75e-06	2.91e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	5.75e-06	2.91e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.72e-06	2.9e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.71e-06	2.89e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.66e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.63e-06	2.85e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.6e-06	2.84e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	5.59e-06	2.83e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.58e-06	2.83e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.57e-06	2.82e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	5.54e-06	2.81e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.51e-06	2.79e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.51e-06	2.79e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.48e-06	2.77e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.46e-06	2.77e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.4e-06	2.73e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.36e-06	2.71e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.14e-06	2.6e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.08e-06	2.57e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.08e-06	2.57e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.07e-06	2.57e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.05e-06	2.56e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.04e-06	2.55e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5e-06	2.53e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.99e-06	2.53e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.99e-06	2.53e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.98e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.98e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.97e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.97e-06	2.52e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.96e-06	2.51e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.96e-06	2.51e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	4.95e-06	2.51e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.94e-06	2.5e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.93e-06	2.49e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.91e-06	2.49e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.9e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.9e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.89e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.88e-06	2.47e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.87e-06	2.46e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.87e-06	2.46e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.84e-06	2.45e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	4.76e-06	2.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.71e-06	2.38e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	4.69e-06	2.38e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.63e-06	2.35e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	4.59e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	4.59e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.58e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	4.56e-06	2.31e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.55e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.54e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.52e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	4.46e-06	2.26e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.42e-06	2.24e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.4e-06	2.23e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	4.39e-06	2.22e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	4.37e-06	2.21e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	4.33e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.28e-06	2.17e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.27e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.21e-06	2.13e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.2e-06	2.13e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.19e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.18e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	4.18e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.17e-06	2.11e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	4.15e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.13e-06	2.09e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.12e-06	2.08e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	4.04e-06	2.04e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.95e-06	2e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	3.9e-06	1.97e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.88e-06	1.97e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.82e-06	1.94e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.82e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.81e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.8e-06	1.92e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.79e-06	1.92e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.75e-06	1.9e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.74e-06	1.89e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	3.7e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	3.54e-06	1.79e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.52e-06	1.78e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.48e-06	1.76e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.4e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	3.38e-06	1.71e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	3.29e-06	1.67e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.24e-06	1.64e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.11e-06	1.58e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.98e-06	1.51e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.94e-06	1.49e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.93e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.92e-06	1.48e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.91e-06	1.47e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.88e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.87e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.86e-06	1.45e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.73e-06	1.38e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.67e-06	1.35e-05	CbGpPWpGaD
